AGM Statement

Genus PLC
18 August 2005


For Immediate Release                                            18 August 2005

                                   GENUS plc

                             Annual General Meeting

                                 Trading Update


At the Annual General Meeting of Genus plc ('Genus') to be held today at 2.30
pm, the Chairman, John Hawkins, will make the following statement:

'During the first quarter, trading throughout the Group has been in line with
management's expectations although, for Bovine Genetics, some market
uncertainties remain in Europe because of the change to the EU agricultural
price support mechanism, as already outlined in the Annual Report.'

'The top bulls, recently introduced to the Genus stud, have contributed
significantly to margins and competitiveness throughout the world.

'Both the subsidiary businesses, Animal Health and Development Consulting, have
continued to progress well.'

Since the publication of the Annual Report & Accounts, Genus has acquired two
small retail businesses, in the cow-dense state of Victoria, Australia. These
companies had a combined turnover of AUS$6.2m (£2.6m) and will combine with the
small retail company acquired in December 2004, and mentioned in the Annual
Report & Accounts, as a route to developing market potential in this important
country.

Contact:
Richard Wood, Chief Executive, Genus plc                           01256 347101
David Timmins, Group Finance Director, Genus plc                   01256 347102

Charles Ryland/Suzanne Brocks, Buchanan Communications            020 7466 5000

About Genus:

Genus is the world's leading Bovine Genetics company. At the core of its
business lies an approximately £9m per year research and development programme.
Laboratory bioscience is used to target and augment traditional mating and
selection programmes testing 400 new bulls each year. The rolling five year
programme aims continuously to improve the genetic make-up of the successive
generations of the bulls created. Semen from the bulls selected from this
programme for stud is sold for use on customers' herds, to improve the output
and stature of their offspring.

Genus distributes beef and dairy semen, both for tropical and temperate
agricultures, from its six studs located in four continents to farmers in
seventy countries. It operates an unrivalled network of overseas selling offices
and exclusive agents. In some countries it also offers insemination services and
the sale of supporting products.

In the UK, Genus Animalcare markets licensed veterinary pharmaceuticals and
Genusxpress wholesales a range of other companies' veterinary pharmaceuticals
and products. Genus also operates an overseas consultancy practice which manages
projects funded by aid agencies for less developed countries.

Genus offers unrivalled expertise in its sector of modern agricultural
technology.




                      This information is provided by RNS
            The company news service from the London Stock Exchange